(Q47861889)

6 February 2018

title

Assessment of pyronaridine activity in vivo and in vitro against the hepatic stages of malaria in laboratory mice (English)

1 reference

6 February 2018

0 references

L K Basco

1

1 reference

6 February 2018

P Ringwald

series ordinal

2

1 reference

6 February 2018

J F Franetich

series ordinal

3

1 reference

6 February 2018

D Mazier

series ordinal

4

1 reference

6 February 2018

publication date

1 November 1999

1 reference

6 February 2018

Transactions of the Royal Society of Tropical Medicine and Hygiene

published in

1 reference

6 February 2018

volume

93

1 reference

6 February 2018

issue

6

1 reference

6 February 2018

page(s)

651-652

1 reference

6 February 2018

Studies on a new antimalarial compound: pyronaridine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990085-8

7 January 2021

Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990085-8

7 January 2021

Effect of antibodies to recombinant and synthetic peptides on P. falciparum sporozoites in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990085-8

7 January 2021

In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990085-8

7 January 2021

Randomised trial of pyronaridine versus chloroquine for acute uncomplicated falciparum malaria in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990085-8

7 January 2021

Pyronaridine for treatment of Plasmodium ovale and Plasmodium malariae infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0035-9203%2899%2990085-8

7 January 2021

10.1016/S0035-9203(99)90085-8

Identifiers

DOI

1 reference

6 February 2018

1 reference

6 February 2018